MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

This study aimed to see if a medication called daratumumab could help improve nerve damage (peripheral neuropathy) in adults with a specific blood condition called MGUS. The trial planned to give participants injections of the drug over six months and measure changes in nerve fun…

This small pilot study is testing whether a 12-week whole food, plant-based diet is practical and helpful for overweight people with early blood cell conditions (MGUS or smoldering myeloma) that can sometimes turn into cancer. Researchers want to see if participants can stick to …

This study is testing whether screening a large population for a common, early blood condition (MGUS) can help prevent or better manage multiple myeloma, a type of blood cancer. Over 80,000 adults in Iceland are having their existing blood samples checked. Those found to have the…

This study is testing whether metformin, a common diabetes medication, can prevent people with early blood cell conditions (MGUS and smoldering myeloma) from developing full multiple myeloma, a type of blood cancer. About 60 participants will take either metformin or a placebo pi…

This study aims to screen 1,000 adults for a blood condition called MGUS, which can sometimes develop into a blood cancer. Researchers want to understand how common MGUS is and learn about the genetic and immune factors linked to it, especially across different ancestral groups. …